United States · FDA National Drug Code directory

Mary Kay Foundation Primer

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51531-0850_297c8c3c-d5db-d017-e063-6294a90a65ce
Product NDC: 51531-0850
Form: GEL
Composition / generic term: avobenzone, homosalate, octisalate, octocrylene
Labeler: Mary Kay Inc.
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20120301
Source listing expiry: 20261231

Source-listed ingredients

AVOBENZONE — 2.5 g/100mL
HOMOSALATE — 9 g/100mL
OCTISALATE — 5 g/100mL
OCTOCRYLENE — 3 g/100mL

These values do not establish equivalence or a dose recommendation.

Packages

.5 mL in 1 PACKET (51531-0850-0) · 51531-0850-0
1 TUBE in 1 CARTON (51531-0850-1) / 29 mL in 1 TUBE · 51531-0850-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →